Ch 13: Blood. What does blood do? Transport: Regulation: Protection:

Similar documents
Physiology Unit 3 HEMATOLOGY

Veins Valves prevent engorgement and backflow. Baroreceptor reflex. Veins returning blood

Chapter 19b Blood, cont d

Overview of Anatomy and Physioloy II Second Year Students

These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.

Sign up to receive ATOTW weekly -

LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY

Blood is 55% Plasma (Liquid)

Introduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO

Upon completion of the Clinical Hematology rotation, the MLS student will be able to:

Laboratory investigation in the Bleeding Patient. Dr Craig Taylor Consultant Haematologist May 2016

Coagulation in perspective: Blood management. Objectives

BLOOD COAGULATION. 1. The initial phase of the process is vascular constriction. This limits the flow of blood to the area of injury.

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy

Blood Product Utilization

The Story of the Platelet Clump. Wayne Hall MTN Network Laboratory Magee-Womens Research Institute Pittsburgh, PA

Drugs used in Thromboembolic Disease. Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2014

Haemostasis. The function of haemostasis is: to prevent blood loss from injured vessels. to stop bleeding. to prevent thrombosis

Special Coagulation - APC Resistance. DiaPharma Group, Inc. Customer Service: Technical Support:

Hematology Emergencies: Problems with Platelets

Methods of Biomaterials Testing. Special Biology: Blood & Vessel

DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK

Quantitative And Spatial Optimization Of Therapeutic Fusion Proteins

*NCCT is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program, provider #122.

The Coagulation Workup In The Office Setting

Activated Protein C Resistance vs Factor V Leiden assay: Which is the most cost effective?

Rheological and biochemical analyses on blood coagulation ~ Discovery of a new pathway under stagnant flow conditions ~

THE SCIENCE OF PLATELET RICH PLASMA

Common Inherited Bleeding Disorders

Lab Guide Hematology Section Lab Guide

Celluvative. Cellular Therapies Redefined. A portfolio of products and services brought to you by: Saving lives today. Improving life tomorrow.

Molecular Analysis of Genes and Gene Products. BIT 220 Chapter 22

RegenACR. autologous cellular regeneration. RegenACR A-PRP treatment. collagen fibers. 1,2 texture and elasticity. 3 volume & strength.

Section 8. To introduce the basic theory and principles of collecting blood for Intraoperative Cell Salvage (ICS)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Iron Deficiency Anemia

Mutations. What is a mutation? a mutation is a change in the sequence of bases in DNA mutations may result in the production of defective proteins

Category Storage Shelf Life Additional Criteria

Page 1. Name: UNIT: GENETICS TOPIC: DNA, GENES, CHROMOSOMES AND PROTEIN SYNTHESIS

OERMATAN SULFATE: A NEW CONCEPT IN ANTITHROMBOTIC THERAPY

Biology 100. ALE #10. From Gene to Protein and Biotechnology Practice Problems DNA

Basic coagulation applications and case studies

Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm

Chapter 3 The Immune System

engineering microvasculature-on-chip models as research-enabling systems for hemostasis and thrombosis

Chapter 10. Oxygen Transporting Proteins

Daily Agenda. Make Checklist: Think Time Replication, Transcription, and Translation Quiz Mutation Notes Download Gene Screen for ipad

Discussion. Objectives:

The Combined Use of Bypassing Agents with Antithrombin Reduction in Plasma of Hemophilia A and B Patients with Inhibitors

Characteristics. Capable of dividing and renewing themselves for long periods of time (proliferation and renewal)

Disclosures. Thromboelastography. TEG Methodology. TEG Output. Thromboelastography (TEG): Basics & Clinical Applications

Apheresis Anticoagulant Removal. Oluwatoyosi Onwuemene, MD MS May 6th, 2017

Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase

The Power in You. TM

EUKARYOTIC REGULATION C H A P T E R 1 3

ASSAY METHODS FOR THE EXPLORATION OF FIBRINOLYSIS

Arthrex Angel TM System. Indication-specific PRP and PRF gel preparations

Pros and Cons of Gene Therapy in ß-Thalassemia

Platelet transfusion therapy. Orieji Illoh, M.D. January 23, 2007

Dr. Suzana Voiculescu

Surgical Adhesives in Facial Plastic Surgery

Serine Proteases and their Inhibitors

2013 W. H. Freeman and Company. 5 Function of Globular Proteins

the tamoxifen treatment schedule used to induce recombination. Arrows indicate on which

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development

Red Cell Transfusion LESSONS FROM TRAUMA

Genetic Basis of Development & Biotechnologies

HEMOSTASIS IN SURGERY

Biological evaluation of medical devices. Part 4: Selection of tests for interactions with blood

Marcia L. Zucker, Ph.D. ZIVD LLC

ROTEM Basic Interpretation Guide

Sysmex CS-2500 Hemostasis System Unrestricted Siemens Healthcare Diagnostics Inc All rights reserved.

Residual Serum Thrombin

R.Li, C.Swaelens, F.Vandermijnsbrugge, B.Cantinieaux BSTH Laboratory of haematology, Porte de Hal,

Laboratory Investigation of Challenging Cases. Laura A. Worfolk, Ph.D Scientific Director, Coagulation

Laboratory Investigation of Challenging Cases. Laura A. Worfolk, Ph.D Scientific Director, Coagulation

Marcia L. Zucker, Ph.D. ZIVD LLC

Hematotoxin producing snakes in Thailand พญ.ม ชฌ มา รอดเช อ พญ.อ สร ย หาญอ ท ยร ศม

From DNA to Protein Structure and Function

Higher Human Biology Unit 1: Human Cells Pupils Learning Outcomes

CLOTTING FACTOR REPLACEMENT THERAPY

Introduction. Principle

Product Data Sheet - TRUEMAB

Profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders

ANAT 3231 Cell Biology Lecture 21 Stem Cells

SAMPLE H21-A5. January 2008

Clinical Policy: Humate-P (Antihemophiliac Factor/von Willebrand Factor Complex Human) Reference Number: CP.MP.404

Globins. The Backbone structure of Myoglobin 2. The Heme complex in myoglobin. Lecture 10/01/2009. Role of the Globin.

PRP Preparation. Simplicity for Success

Page 3. 18) The diagram below illustrates some key steps of a procedure in one area of biotechnology.

Appendix B. Glossary of Acronyms and Terms

DNA & DNA Replication

Murine TGFβ-antagonist (RAP-1332) Inhibits Fibrosis in a Murine Model of Myelofibrosis. Rajasekhar NVS Suragani, PhD

AVOIDING ANTICOAGULATION in CRRT: An update on EMERGING MEMBRANES Available in 2012

Transcription:

Ch 13: Blood What does blood do? Transport: Regulation: Protection:

SLOs Describe the composition of plasma and list the major functions of plasma proteins. Map hematopoiesis, starting from a pluripotent hematopoietic stem cell. Distinguishing characteristics of each type of leukocyte. Define hematocrit, describe how a person s hematocrit is determined, and identify the clinical relevance of this value. Describe the molecular structure of hemoglobin and explain its function. Distinguish between the different types of anemias. Diagram the key steps of hemostasis, the coagulation cascade, and fibrinolysis.

Blood = connective tissue Extracellular matrix: Specialized cells: Average adult blood volume?

Fig 13.1

Function of plasma proteins?

Cellular Components of Blood - Overview 20-40% Total WBC: 4,000-11,000 Cellular Elements 2-8% 50-70% 1-4%

Blood Cells and Platelets Fig 13-3

Red Blood Cells Other name?

Hem(at)opoiesis = Blood Cell Formation Few uncommitted stem cells in red bone marrow throughout life time Controlled by, specifically CSFs and ILs

Stages of Erythropoiesis 2.5 million RBCs/sec Whole process takes 3 days Most iron recycled from old RBCs, rest from diet Transferrin =? Fig 13-4

Erythropoiesis EPO release Mitotic rate Tissue O 2 Maturation speed RBC bag of Hb for carrying O 2 lifespan ~ 120 days No aerobic respiration source of ATP? Tissue O 2 Reticulocytes enter circulation

RBC Production Regulated by Hormone synthesized by kidneys in response to hypoxemia due to anemia blood flow to kidneys declining O 2 content of air in lungs declining, due to disease or high altitude respiratory surfaces of the lungs damaged EPO gene cloned in 1985 Recombinant EPO now available

EPO Use in therapy (?) abuse in sport (?)

See Ch 16, page 559! Hemoglobin (Hb) Quaternary protein structure? Requires iron (Fe) HbA vs. HbF vs. HbS Reversible binding between Fe 2+ & O 2 Oxyhemoglobin vs. deoxyhemoglobin Carboxyhemoglobin CO: A toxic gas (Fitness Application p. 560)

RBC Disorders Polycythemia vera (PCV ~ 60-70%) Anemias (O 2 carrying capacity too ) Hemorrhagic anemia Fe deficiency anemia Hemolytic anemia, due to genetic diseases (e.g. Hereditary spherocytosis) or infections Pernicious anemia see p. 714 Renal anemia Aplastic anemia

Sickle Cell Anemia 1 st genetic illness traced to a specific mutation: DNA: CAC CTC aa: glutamic acid valine (aa #6 of 146) HbA HbS crystallizes under low oxygen conditions

Platelets = Thrombocytes Cytokine stimulating platelet production? Precursor cell in BM: ; polyploid Mechanism? ~ 4,000 platelets per cell Fig 16-7 live ~ 5-9 days Platelets contain granules filled with clotting proteins & cytokines (e.g.: serotonin) Activated when blood vessel wall damaged

Hemostasis = stops bleeding. Opposite of hemorrhage. Too little hemostasis Too much hemostasis Three major steps of hemostasis: 1. Vasoconstriction 2. Platelet plug (temporary blockage of hole) 3. Coagulation (clot formation seals hole until tissues repaired)

Steps of Hemostasis Vessel damage exposes collagen fibers Platelets adhere to collagen & release factors + feedback loop local vasoconstriction & platelet aggregation decreased blood flow platelet plug formation

Simultaneously: The Coagulation Cascade Fig 13-9 Cascade is complicated network! Numbering of coagulation factors according to time of discovery

Common Coagulation Pathway Intrinsic pathway Extrinsic pathway Active factor X Prothrombin thrombin fibrinogen fibrin reinforces platelet plug clot

Structure of Blood Clot Plasmin, trapped in clot, will dissolve clot by fibrinolysis SEM x 4625 Clot formation limited to area of injury: Intact endothelial cells release anticoagulants (heparin, antithrombin III, protein C).

Clot Busters & Anticoagulants Dissolve inappropriate clots Enhance fibrinolysis Examples: Urokinase, Streptokinase & t-pa Prevent coagulation by blocking one or more steps in fibrin forming cascade Inhibit platelet adhesion plug prevention Examples:

Hemophilia A

Hemophilia A (Factor VIII Deficiency)